ABIONYX Pharma SA (EPA:ABNX)
France · Delayed Price · Currency is EUR 1.880
+0.024 (1.29%)
Aug 3, 2026, 1:25 PM CET
ABIONYX Pharma Market Cap
ABIONYX Pharma has a market cap or net worth of €65.5 million as of August 3, 2026. Its market cap has increased by 18.06% in one year.
Market Cap
65.50M
Enterprise Value
65.79M
Revenue
4.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.88
ChartMarket Cap Chart
Since March 30, 2015, ABIONYX Pharma's market cap has decreased from 214.16M to 65.50M, a decrease of -69.41%. That is a compound annual growth rate of -9.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 3, 2026 | 65.50M | -50.94% |
| Dec 31, 2025 | 133.53M | 223.58% |
| Dec 31, 2024 | 41.27M | -0.54% |
| Dec 29, 2023 | 41.49M | -14.37% |
| Dec 30, 2022 | 48.45M | -28.38% |
| Dec 31, 2021 | 67.65M | 178.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 179.18M |
| Sensorion | 146.18M |
| Innate Pharma | 143.70M |
| Adocia | 77.48M |
| OSE Immunotherapeutics | 75.41M |
| THX Pharma Société Anonyme | 59.33M |
| MaaT Pharma | 52.39M |
| Fermentalg | 44.28M |